TITLE

Identification of collaboration patterns of dysfunctional pathways in breast cancer

AUTHOR(S)
Xinyong Zhu; Lianyuan Tao; Jing Yao; Pengjun Sun; Lijuan Pei; Jiye Li; Zhihua Long; Ye Wang; Fengliang Zhang
PUB. DATE
July 2014
SOURCE
International Journal of Clinical & Experimental Pathology;2014, Vol. 7 Issue 7, p3853
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
97436046

 

Related Articles

  • Novel Targets in Cancer Therapy. Banerjee, Debabrata // Current Pharmaceutical Biotechnology;Feb2009, Vol. 10 Issue 2, p147 

    The article discusses reports on developments in the field of cancer research including one on identification of novel targets in breast cancer and another on the notch signalling pathway.

  • Polygenic or Pollyanna? Foulkes, William D. // Nature Medicine;Apr2002, Vol. 8 Issue 4, p328 

    Focuses on the risk factors in breast cancer. Factors responsible for familial clustering of breast cancer; Identification of genes responsible for breast cancer.

  • Basal Breast Cancer: A Complex and Deadly Molecular Subtype. Bertucci, F.; Finetti, P.; Birnbaum, D. // Current Molecular Medicine;Jan2012, Vol. 12 Issue 1, p96 

    During the last decade, gene expression profiling of breast cancer has revealed the existence of five molecular subtypes and allowed the establishment of a new classification. The basal subtype, which represents 15-25% of cases, is characterized by an expression profile similar to that of...

  • Integrating Multi-Omics for Uncovering the Architecture of Cross-Talking Pathways in Breast Cancer. Wang, Li; Xiao, Yun; Ping, Yanyan; Li, Jing; Zhao, Hongying; Li, Feng; Hu, Jing; Zhang, Hongyi; Deng, Yulan; Tian, Jiawei; Li, Xia // PLoS ONE;Aug2014, Vol. 9 Issue 8, p1 

    Cross-talk among abnormal pathways widely occurs in human cancer and generally leads to insensitivity to cancer treatment. Moreover, alterations in the abnormal pathways are not limited to single molecular level. Therefore, we proposed a strategy that integrates a large number of biological...

  • Identification and prioritization of candidate genes for symptom variability in breast cancer survivors based on disease characteristics at the cellular level. Koleck, Theresa A.; Conley, Yvette P. // Breast Cancer: Targets & Therapy;Mar2016, Vol. 8, p29 

    Research is beginning to suggest that the presence and/or severity of symptoms reported by breast cancer survivors may be associated with disease-related factors of cancer. In this article, we present a novel approach to the identification and prioritization of biologically plausible candidate...

  • Artists in the pink for charity.  // Evening Standard;10/23/2014, p21 

    TWO London artists have collaborated on an artwork to support breast cancer awareness.

  • Mammary Development and Breast Cancer: The Role of Stem Cells. Ercan, C.; van Diest, P. J.; Vooijs, M. // Current Molecular Medicine;Jun2011, Vol. 11 Issue 4, p270 

    The mammary gland is a highly regenerative organ that can undergo multiple cycles of proliferation, lactation and involution, a process controlled by stem cells. The last decade much progress has been made in the identification of signaling pathways that function in these stem cells to control...

  • Natural history and prognosis of recurrent breast cancer. Karabali-Dalamaga, S.; Souhami, R.L.; O'Higgins, N.J.; Soumilas, A.; Clark, C.G. // British Medical Journal;9/9/1978, Vol. 2 Issue 6139, p730 

    Investigates the patterns of the recurrence of breast cancer. Survival of patients with breast cancer; Availability of information on breast cancer management; Effects of postoperative radiotherapy in the dissemination of tumor.

  • Breast cancer: Straight answers from the experts.  // Glamour;July97, Vol. 95 Issue 7, p44 

    Presents a question and answer segment on breast cancer. Best exam pattern to use; Breast cancer risks; Effects of exercise on a woman's risks of catching breast cancer.

  • BRCA1 - Conductor of the Breast Stem Cell Orchestra: The Role of BRCA1 in Mammary Gland Development and Identification of Cell of Origin of BRCA1 Mutant Breast Cancer. Buckley, Niamh; Mullan, Paul // Stem Cell Reviews & Reports;Sep2012, Vol. 8 Issue 3, p982 

    Breast cancer treatment has been increasingly successful over the last 20 years due in large part to targeted therapies directed against different subtypes. However, basal-like breast cancers still represent a considerable challenge to clinicians and scientists alike since the pathogenesis...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics